Nautilus Biotechnology, Inc.

NAUT

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001856744-26-000001
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+160,000.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

160,000.0

Filing's footnotes

1. Subject to reporting person's continuous status as a &quot;Service Provider&quot; (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.